Caffeine for Infants Born at 28 to 34 Weeks Receiving Respiratory Support (NCT07456670)
Caffeine Therapy in Preterm Infants Born at 28-34 Weeks: A Pilot Placebo-Controlled Randomized Controlled Trial
🩺 Plain-English Summary (8th-Grade Level)
The goal of this pilot clinical trial is to test if it is possible to conduct a larger study on the use of caffeine in preterm infants who need help with their breathing. It will also look at whether caffeine helps these infants get healthy enough to leave the hospital sooner. The main questions the researchers aim to answer are: Can the investigators successfully recruit and keep enough participants in the study? Do the medical teams follow the study drug instructions correctly? Does caffeine reduce the total time infants spend in the Neonatal Intensive Care Unit (NICU)? Researchers will compare caffeine to a placebo (a look-alike substance with no active medicine) to see if caffeine is a helpful treatment for babies born between 28 and 34 weeks of gestation who are using a breathing machine or oxygen. Participants will: Be randomly assigned to receive either caffeine or a placebo through an IV or a feeding tube. Receive the study treatment once a day as long as they require respiratory support (and for 24 hours after they stop). Be monitored by the research team for clinical outcomes like feeding progress, breathing stability, and growth until they are discharged from the hospital.
Who can join: Review the eligibility criteria below.
Location: Kingston Health Science Center — Kingston, Ontario
Age range: 0 Days to 28 Days
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Kingston Health Science Center — Kingston, Ontario
📞 Contact the Study Coordinator
Phone: (613) 548-6053
Email: eyad.bitar@queensu.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Preterm Birth
- Targeting Human Milk Fortification to Improve Preterm Infant Growth and Brain Development — Boston, Massachusetts
- Omega Tots Long Term Follow-up — Columbus, Ohio
- Nurse-Family Partnership Impact Evaluation in South Carolina — Anderson, South Carolina
- Promoting Kangaroo Care for Preterm or Low Birthweight Infants in Rural India — Worcester, Massachusetts
- The Use of Wireless Sensors in Neonatal Intensive Care — Montreal, Quebec
- Music Intervention for Preterm Birth — New York, New York
Explore by condition: All Preterm Birth clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.